| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/BMM.09.22 |
| P698 | PubMed publication ID | 20477478 |
| P2093 | author name string | Narasimhamurthy Shanaiah | |
| G A Nagana Gowda | |||
| Omkar B Ijare | |||
| Tedros Bezabeh | |||
| P2860 | cites work | HMDB: a knowledgebase for the human metabolome | Q24655295 |
| Versatile new ion source for the analysis of materials in open air under ambient conditions | Q28244968 | ||
| Mass spectrometry sampling under ambient conditions with desorption electrospray ionization | Q28288035 | ||
| Chemometrics in metabonomics. | Q30359585 | ||
| Megavariate data analysis of mass spectrometric proteomics data using latent variable projection method | Q30825102 | ||
| Gas chromatography/mass spectrometry in metabolic profiling of biological fluids | Q30843536 | ||
| Improved methods for the acquisition and interpretation of NMR metabolomic data | Q30882018 | ||
| Mapping high-dimensional data onto a relative distance plane--an exact method for visualizing and characterizing high-dimensional patterns | Q30970611 | ||
| 1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media | Q31027751 | ||
| Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies | Q31029583 | ||
| One-step analysis of major bile components in human bile using 1H NMR spectroscopy | Q31061373 | ||
| Analytical strategies in metabonomics | Q31097049 | ||
| Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis | Q33287430 | ||
| Improved identification of metabolites in complex mixtures using HSQC NMR spectroscopy | Q33329006 | ||
| Analysis of metabolomic data using support vector machines | Q33366103 | ||
| Metabolite profiling of fecal water extracts from human colorectal cancer | Q33384170 | ||
| Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends | Q33440434 | ||
| Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. | Q46632104 | ||
| Analysis of acetylcholine, choline and butyrobetaine in human liver tissues by hydrophilic interaction liquid chromatography-tandem mass spectrometry | Q46648773 | ||
| Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry | Q46693936 | ||
| Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma | Q47233148 | ||
| Systems biology: Metabonomics | Q47647280 | ||
| Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. | Q50155338 | ||
| Monitoring diet effects via biofluids and their implications for metabolomics studies. | Q51482412 | ||
| Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. | Q51925297 | ||
| Metabonomic assessment of physiological disruptions using 1H-13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. | Q52546214 | ||
| 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats. | Q53466508 | ||
| High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. | Q53623717 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Proposed minimum reporting standards for data analysis in metabolomics | Q56974474 | ||
| The human cerebrospinal fluid metabolome | Q57014395 | ||
| Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis | Q57098552 | ||
| Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy | Q57099991 | ||
| Automated screening for metabolites in complex mixtures using 2D COSY NMR spectroscopy | Q57803464 | ||
| NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches | Q58046056 | ||
| Combined HPLC, NMR Spectroscopy, and Ion-Trap Mass Spectrometry with Application to the Detection and Characterization of Xenobiotic and Endogenous Metabolites in Human Urine | Q58046328 | ||
| An Accurate Method for Cholesterol Analysis in Bile | Q58178782 | ||
| Metabolomics: Biochemistry's new look | Q59073639 | ||
| Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry | Q34500109 | ||
| Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues | Q34526755 | ||
| Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts | Q34714204 | ||
| 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies | Q34808133 | ||
| Metabolic phenotyping in health and disease | Q34822429 | ||
| Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR. | Q35880308 | ||
| Mass spectrometry in metabolome analysis. | Q35897249 | ||
| Metabolomics applications of FT-ICR mass spectrometry | Q35897295 | ||
| In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. | Q36075759 | ||
| Microcoil nuclear magnetic resonance spectroscopy | Q36222332 | ||
| Metabolomics: the principles and potential applications to transplantation. | Q36319505 | ||
| Metabonomics techniques and applications to pharmaceutical research & development | Q36484646 | ||
| 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance | Q36771346 | ||
| Mass spectrometry-based "omics" technologies in cancer diagnostics | Q36778885 | ||
| Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells | Q36866923 | ||
| Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover | Q36942649 | ||
| In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model | Q37130784 | ||
| Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis | Q37209712 | ||
| Metabolomics-based methods for early disease diagnostics | Q37266489 | ||
| Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy | Q38486994 | ||
| Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). | Q39907905 | ||
| Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice | Q40223413 | ||
| A comprehensive urinary metabolomic approach for identifying kidney cancerr | Q40240301 | ||
| (1)H and (31)P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection | Q40407875 | ||
| Fucose in1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells | Q41672101 | ||
| Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer | Q41935417 | ||
| Image localized 31P magnetic resonance spectroscopy of the human liver | Q43524905 | ||
| Directly coupled HPLC-NMR and HPLC-MS approaches for the rapid characterisation of drug metabolites in urine: application to the human metabolism of naproxen | Q43555731 | ||
| Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: application to the analysis of acetaminophen metabolites in urine | Q44377914 | ||
| A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity | Q44902497 | ||
| Phosphodiesters in saponified extracts of human breast and colon tumors using 31P magnetic resonance spectroscopy | Q44932644 | ||
| A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry | Q45014825 | ||
| Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures. | Q45226394 | ||
| Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. | Q45952258 | ||
| Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS. | Q46155579 | ||
| Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue | Q46165483 | ||
| Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry. | Q46397575 | ||
| Quantification of glycine and taurine conjugated bile acids in human bile using 1H NMR spectroscopy | Q46500541 | ||
| A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats | Q46518284 | ||
| Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. | Q46535719 | ||
| Stones from cancerous and benign gallbladders are different: A proton nuclear magnetic resonance spectroscopy study | Q46571791 | ||
| Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. | Q46601132 | ||
| P433 | issue | 3 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 307-322 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery | |
| P478 | volume | 3 |
| Q37734427 | Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers |
| Q36581517 | Isotope enhanced approaches in metabolomics |
| Q30842175 | MRS-based Metabolomics in Cancer Research |
| Q37923938 | NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile |
| Q37801938 | Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics |
| Q28083342 | Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review |
Search more.